DexCom (BSP:D1EX34) E10: R$0.09 (As of Mar. 2026)


BSP:D1EX34 DexCom Inc BSP:D1EX34
85 GF Score
Price R$7.66
GF Value R$10.83
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom E10?

DexCom BSP:D1EX34 +2.54% 85 E10 is R$0.09 as of Mar. 2026. GuruFocus rates BSP:D1EX34 with a GF Score™ of 85/100 and a GF Value™ of R$10.83 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

DexCom's adjusted earnings per share data for the three months ended in Mar. 2026 was R$0.053. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$0.09 for the trailing ten years ended in Mar. 2026.

During the past 12 months, DexCom's average E10 Growth Rate was 54.70% per year. During the past 3 years, the average E10 Growth Rate was 60.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of DexCom was 91.30% per year. The lowest was 8.80% per year. And the median was 14.80% per year.

As of today (2026-07-08), DexCom's current stock price is R$7.66. DexCom's E10 for the quarter that ended in Mar. 2026 was R$0.09. DexCom's Shiller PE Ratio of today is 85.11.

During the past 13 years, the highest Shiller PE Ratio of DexCom was 5379.50. The lowest was 73.91. And the median was 404.62.


DexCom  (BSP:D1EX34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

DexCom's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.66/0.09
=85.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of DexCom was 5379.50. The lowest was 73.91. And the median was 404.62.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


DexCom E10 Related Terms


DexCom E10 Historical Data

* Premium members only.

The historical data trend for DexCom's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom E10 Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.02 0.03 0.06 0.08

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.07 0.08 0.09

BSP:D1EX34 vs GEHC, STE, ZBH: E10 Comparison

For the Medical Devices subindustry, DexCom's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where DexCom's Shiller PE Ratio falls into.


BSP:D1EX34
85GF Score
DexCom Inc BSP:D1EX34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DexCom's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.053/330.2130*330.2130
=0.053

Current CPI (Mar. 2026) = 330.2130.

DexCom Quarterly Data

per share eps CPI Adj_EPS
201606 -0.004 241.018 -0.005
201609 -0.004 241.428 -0.005
201612 -0.002 241.432 -0.003
201703 -0.008 243.801 -0.011
201706 0.000 244.955 0.000
201709 0.000 246.819 0.000
201712 -0.002 246.524 -0.003
201803 -0.005 249.554 -0.007
201806 0.006 251.989 0.008
201809 0.011 252.439 0.014
201812 -0.039 251.233 -0.051
201903 -0.006 254.202 -0.008
201906 -0.002 256.143 -0.003
201909 0.010 256.759 0.013
201912 0.021 256.974 0.027
202003 0.005 258.115 0.006
202006 0.012 257.797 0.015
202009 0.020 260.280 0.025
202012 0.093 260.474 0.118
202103 0.016 264.877 0.020
202106 0.019 271.696 0.023
202109 0.022 274.310 0.026
202112 -0.006 278.802 -0.007
202203 0.023 287.504 0.026
202206 0.012 296.311 0.013
202209 0.025 296.808 0.028
202212 0.023 296.797 0.026
202303 0.013 301.836 0.014
202306 0.027 305.109 0.029
202309 0.029 307.789 0.031
202312 0.061 306.746 0.066
202403 0.036 312.332 0.038
202406 0.038 314.175 0.040
202409 0.038 315.301 0.040
202412 0.046 315.605 0.048
202503 0.031 319.799 0.032
202506 0.050 322.561 0.051
202509 0.075 324.800 0.076
202512 0.074 324.054 0.075
202603 0.053 330.213 0.053

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$0.09 mean?
DexCom (BSP:D1EX34) has a E10 of R$0.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on DexCom and its competitors.
Is DexCom's E10 too high?
DexCom's current E10 is R$0.09. Overall, DexCom has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's E10 compare to GEHC and STE?
DexCom's E10 of R$0.09 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on DexCom and its competitors. DexCom's current E10 is R$0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (BSP:D1EX34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$10.83, compared to a current price of R$7.66 — trading 29.3% below its estimated fair value. The current E10 is R$0.09. DexCom's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For DexCom (BSP:D1EX34), the current E10 is R$0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (BSP:D1EX34) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of R$7.66 is trading 29.3% below its estimated GF Value™ of R$10.83. GuruFocus considers DexCom to be Modestly Undervalued.

Key valuation signals for BSP:D1EX34:

  • E10: R$0.09
  • GF Value™: R$10.83 vs. price of R$7.66 (29.3% below fair value)
  • GF Score™: 85/100 with 3 warning signs

No single metric tells the full story. See the BSP:D1EX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
85GF Score

Get the complete analysis for BSP:D1EX34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$7.66
Price
R$10.83
GF Value